Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases

Genes Chromosomes and Cancer

Volumn 36, Issue 4, 2003, Pages 353-360

  Albano, Francesco ^a   Specchia, Giorgina ^a,b   Anelli, Luisa ^a,b   Zagaria, Antonella ^a   Storlazzi, Clelia Tiziana ^a   Buquicchio, Caterina ^a   Roberti, Maria Grazia ^b   Liso, Vincenzo ^a   Rocchi, Mariano ^a,c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c DAPEG   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; FLUDARABINE; GAMMA INTERFERON; IMATINIB; MITOXANTRONE;

ADULT; ARTICLE; BLAST CELL; CASE REPORT; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE MARKER; GENE DELETION; GENE TRANSLOCATION; HEPATOSPLENOMEGALY; HUMAN; HYPOTHESIS; LABORATORY TEST; LEUKOCYTOSIS; MALE; MOLECULAR GENETICS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; BONE MARROW CELLS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; CYTOGENETIC ANALYSIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; TRANSLOCATION, GENETIC; VARIATION (GENETICS);

EID: 0037377077     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10183     Document Type: Article

References (33)

1. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. 1996. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297.
2. Chinnadurai G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9:213-224.
3. Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G, Trakhtenbrot L. 2001. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene. Expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet 128:114-119.
4. Cook WD, McCaw BJ. 2000. Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene 19:3434-3438.
5. Fitzgerald PH, Morris CM. 1991. Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet 57:143-151.
6. Haase D, Binder C, Bunger J, Fonatsch C, Streubel B, Schnittger S, Griesinger F, Westphal G, Schoch C, Knopp A, Berkovicz D, Krieger O, Wormann B, Hilgers R, Hallier E, Schulz T. 2002. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 26:249-254.
7. Hagemeijer A, de Klein A, Godde-Salz E, Turc-Carel C, Smit EM, van Agthoven AJ, Grosveld GC. 1985. Translocation of c-abl1 to "masked" Ph in chronic myeloid leukemia. Cancer Genet Cytogenet 18:95-104.
8. Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, Wahl AF. 1996. Cyclin G1 and Cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem 271:6050-6061.
9. Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. 2001. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98:1732-1738.
10. Igney FH, Krammer PH. 2002. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2:277-288.
11. Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ. 2001. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Gene Dev 15:2934-2939.
12. Johansson B, Fioretos T, Mitelman F. 2002. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76-94.
13. Kapanadze B, Kashuba V, Baranova A, Rasool O, van Everdink W, Liu Y, Syomova A, Corcoran M, Poltaraus A, Brodyansky V, Syomova N, Kazakov A, Ibbotson R, van den Berg A, Gizatullin R, Fedorova L, Sulimova G, Zelenin A, Deaven L, Lehrach H, Grander D, Buys C, Oscier D, Zabarovsky ER, Einhorn S, Yankovsky N. 1998. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5. FEBS Lett 426:266-270.
14. Knudson AG Jr. 1985. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443.
15. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA. 2001. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97: 3581-3588.
16. Lichter P, Tang Chang CJ, Call K, Hermanson G, Evans GA, Housman D, Ward DC. 1990. High resolution mapping of human chromosomes 11 by in situ hybridization with cosmid clones. Science 247:64-69.
17. Mertens D, Wolf S, Schroeter P, Schaffner C, Dohner H, Stilgenbauer S, Lichter P. 2002. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116-4121.
18. Mitelman F, editor. 1995. An international system for human cytogenetic nomenclature. Basel: S. Karger.
19. Mitelman F, Johansson B, Mertens F, editors. 2002. Mitelman database of chromosome aberrations in cancer. May be accessed at http://cgap.nci.nih.gov/Chromosomes/Mitelman
20. Ortega S, Malumbres M, Barbacid M. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602:73-87.
21. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM. 1998. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431:351-356.
22. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
23. Popenoe DW, Schaefer-Rego K, Mears JG, Bank A, Leibowitz D. 1986. Frequent and extensive deletion during the 9;22 translocation in CML. Blood 68:1123-1128.
24. Quon KC, Berns A. 2001. Haplo-insufficiency? Let me count the ways. Gene Dev 15:2917-2921.
25. Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O. 1999. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8:2359-2368.
26. Shtalrid M, Talpaz M, Kurzrock R, Kantarjian H, Trujillo J, Gutterman J, Yoffe G, Blick M. 1988. Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood 72: 485-490.
27. Shtivelman E, Lifshitz B, Gale RP, Canaani E. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550-554.
28. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR. 2000. Large deletions at the t(9;22) breakpoint are common and may identify a poor prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738-743.
29. Storlazzi CT, Specchia G, Anelli L, Albano F, Pastore D, Zagaria A, Rocchi M, Liso V. 2002. Breakpoint characterization of der(9) deletions in CML patients. Genes Chromosomes Cancer 35:271-276.
30. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diaz MG, Malec M, Langerak AW, San Miguel JF, Biondi A. 1999. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13:1901-1928.
31. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. 1998. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394: 203-206.
32. Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S, Lichter P. 2001. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 10:1275-1285.
33. Zhang HS, Postigo AA, Dean DC. 1999. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16(INK4a), TGF-beta, and contact inhibition. Cell 97:53-61.